Le Lézard
Classified in: Health
Subjects: NPT, FVT

Academy of Managed Care Pharmacy (AMCP) Foundation and Genentech Offered Summer Internships in Managed Care Pharmacy


ALEXANDRIA, Va., Oct. 6, 2017 /PRNewswire-USNewswire/ -- The Academy of Managed Care Pharmacy (AMCP) Foundation is delighted to announce that two student pharmacists recently completed a summer internship organized by the Foundation and supported by Genentech, Inc. The interns executed capstone research projects, which will be delivered via poster presentations at AMCP Nexus 2017, Oct. 16-19, in Dallas, Texas.

www.amcp.org/amcp-foundation

The highly competitive national internship offers future practitioners the opportunity to gain firsthand knowledge of the biotechnology industry. This year's participants will join the ranks of 165 alumni who have completed Foundation-organized internships over the years.

"The real-world training made possible by Genentech is invaluable in grooming the next generation of health care decision-makers," says Paula J. Eichenbrenner, CAE, Executive Director of the AMCP Foundation. "We are so proud of these talented young pharmacists! This immersive educational experience also assists the efforts of school of pharmacy faculty to expose more student pharmacists to managed care."

In its first year, the AMCP Foundation/Genentech, Inc. Evidence for Access Summer Internship provides an opportunity for interns to contribute to meaningful projects and interact with industry experts within the Evidence for Access Team US Medical Affairs at Genentech. Both interns were placed at Genentech in San Francisco, Calif. They are:

In addition to the rigorous onsite experience at Genentech, the interns learned about AMCP and the Foundation via "virtual" preceptors and a one-week rotation at the AMCP/Foundation headquarters in Alexandria, Va. View their research results during the poster presentations in The Exchange at Nexus on Wednesday, October 18, from 12:00-2:45 p.m.

About AMCP Foundation:  
Established in 1990, the 501(c)3 nonprofit AMCP Foundation is the philanthropic arm of the Academy of Managed Care Pharmacy (AMCP). It exists to advance collective knowledge and insights on major issues associated with the practice of pharmacy in managed health care settings. By facilitating innovative research initiatives and providing educational opportunities to learn about managed care pharmacy, the AMCP Foundation invests in the future of managed care. Visit www.amcpfoundation.org.

About AMCP
The Academy of Managed Care Pharmacy (AMCP) is the nation's leading professional association dedicated to increasing patient access to affordable medicines, improving health outcomes and ensuring the wise use of health care dollars. Through evidence- and value-based strategies and practices, the Academy's 8,000 pharmacists, physicians, nurses and other practitioners manage medication therapies for the 270 million Americans served by health plans, pharmacy benefit management firms, emerging care models and government. www.amcp.org

SOURCE Academy of Managed Care Pharmacy (AMCP) Foundation


These press releases may also interest you

at 23:38
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

at 23:33
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIOŽ (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: